Literature DB >> 1691014

Synthesis and biophysical characterization of engineered topographic immunogenic determinants with alpha alpha topology.

P T Kaumaya1, K D Berndt, D B Heidorn, J Trewhella, F J Kezdy, E Goldberg.   

Abstract

Model peptides with predetermined secondary, tertiary, and quaternary conformation have been successfully designed, synthesized, and characterized in an attempt to mimic the three-dimensional structure of an antigenic determinant. This work is a continuing effort to map the antigenic structure of the protein antigen lactate dehydrogenase C4 (LDH-C4) to develop a contraceptive vaccine. A putative topographic determinant with alpha alpha topology which associates into four-helix bundles was designed on the basis of the framework model of protein folding. An idealized amphiphilic 18-residue sequence (alpha 1) and a 40-residue alpha alpha fold (alpha 3) have been shown to form stable 4-helix structures in solution with a free energy of association on the order of -20.8 kcal/mol (tetramerization of alpha 1) and -7.8 kcal/mol (dimerization of alpha 3). Both alpha 1 and alpha 3 form stable monolayers at the air-water interface. The CD spectra of Langmuir-Blodgett monolayers are characteristically alpha-helical. Both CD and FTIR spectroscopic studies reval a high degree of secondary structure. The SAXS data strongly suggest that the helices are arranged in a four-helix bundle since the radius of gyration of 17.2 A and the vector distribution function are indicative of a prolate ellipsoid of axial dimensions and molecular weight appropriate for the four-helix bundle. The major contribution to the formation and stabilization of alpha 1 and alpha 3 is believed to be hydrophobic interaction between the amphiphilic alpha-helices. The displayed heptad repeat, helix dipole, ion pairs, and the loop sequence may have also contributed to the overall stability and antiparallel packing of the helices. A detailed structural analysis of a relevant topographic immunogenic determinant will elucidate the nature of antigen-antibody interactions as well as provide insight into protein folding intermediates.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691014     DOI: 10.1021/bi00453a002

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

Review 1.  A paradigm shift: Cancer therapy with peptide-based B-cell epitopes and peptide immunotherapeutics targeting multiple solid tumor types: Emerging concepts and validation of combination immunotherapy.

Authors:  Pravin T P Kaumaya
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 2.  Heat shock proteins and immune responses: an early view.

Authors:  D C DeNagel; S K Pierce
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  The non-ligand binding beta-isoform of the human glucocorticoid receptor (hGR beta): tissue levels, mechanism of action, and potential physiologic role.

Authors:  M de Castro; S Elliot; T Kino; C Bamberger; M Karl; E Webster; G P Chrousos
Journal:  Mol Med       Date:  1996-09       Impact factor: 6.354

4.  Human S100b protein: formation of a tetramer from synthetic calcium-binding site peptides.

Authors:  C Donaldson; K R Barber; C M Kay; G S Shaw
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725

Review 5.  Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy.

Authors:  Pravin T P Kaumaya; Kevin Chu Foy
Journal:  Future Oncol       Date:  2012-08       Impact factor: 3.404

Review 6.  Overview of vaccines.

Authors:  G Ada
Journal:  Mol Biotechnol       Date:  1997-10       Impact factor: 2.695

7.  Folded conformations of antigenic peptides from riboflavin carrier protein in aqueous hexafluoroacetone.

Authors:  S Bhattacharjya; S K Awasthi; P R Adiga; P Balaram
Journal:  Protein Sci       Date:  1998-01       Impact factor: 6.725

8.  Epitope mapping of the outer membrane protein P5-homologous fimbrin adhesin of nontypeable Haemophilus influenzae.

Authors:  L A Novotny; J A Jurcisek; M E Pichichero; L O Bakaletz
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

9.  Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.

Authors:  M D Lairmore; A M DiGeorge; S F Conrad; A V Trevino; R B Lal; P T Kaumaya
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  Total chemical synthesis, characterization, and immunological properties of an MHC class I model using the TASP concept for protein de novo design.

Authors:  G Tuchscherer; C Servis; G Corradin; U Blum; J Rivier; M Mutter
Journal:  Protein Sci       Date:  1992-10       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.